As of 2025-11-02, the Fair Value of Enanta Pharmaceuticals Inc (ENTA) is -16.50 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 10.96 USD, the upside of Enanta Pharmaceuticals Inc is -250.56%.
With the market price of 10.96 USD and our fair value calculation, Enanta Pharmaceuticals Inc (ENTA) is not a good investment. Investing in ENTA stocks now will result in a potential loss of 250.56%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 5Y Avg | |
| Net income | -36.20 | -79.00 | -121.80 | -133.80 | -116.04 | -97.37 |
| YoY growth | -178.02% | -118.23% | -54.18% | -9.85% | 13.27% | -69.40% |
| Market Cap (mil) | 305.56 |
| P/E | |
| Forward P/E |
| EPS | -3.30 |
| Avg earnings growth rate | -69.40% |
| TTM earnings | -92.01 |